Results 71 to 80 of about 1,759 (167)
Brain olfactory‐related atrophy in isolated rapid eye movement sleep behavior disorder
Objective To investigate structural and functional connectivity changes in brain olfactory‐related structures in a longitudinal prospective cohort of isolated REM sleep behavior disorder (iRBD) and their clinical correlations, longitudinal evolution, and
Kyung Ah Woo +7 more
doaj +1 more source
Background: Pharmacogenomics (PGx) can provide more precision in determining causation of adverse drug reactions (ADRs) from drug-drug-gene interaction clinical application.
Jade Nanan +2 more
doaj +1 more source
Abstract Background Isolated RBD (iRBD) is a prominent early marker of Parkinson's disease and related disorders. Objectives Evaluate biomarkers of inflammation and axonal damage people with iRBD for disease progression. Methods Plasma samples from 27 video‐polysomnography confirmed iRBD patients and 25 controls were analyzed for inflammatory ...
Brook Huxford +6 more
wiley +1 more source
Pharmacist assessment of drug-gene interactions and drug-induced phenoconversion in major depressive disorder: a case report [PDF]
Nicole Marie Del Toro-Pagán +5 more
openalex +1 more source
Basal Forebrain Volume Predicts Disease Conversion in Prodromal Synucleinopathy
Abstract Background Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal stage of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). The basal forebrain (BF), a key cholinergic structure, is a site of known pathology in later stages of Lewy body disorders.
Lachlan Churchill +5 more
wiley +1 more source
Derivation and Validation of a Phenoconversion‐Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder [PDF]
Pietro Mattioli +22 more
openalex +1 more source
ABSTRACT Background The onset and pattern of progression of swallowing impairment in HD remain poorly understood. The Swallowing Disturbance Questionnaire (SDQ) has proven useful in assessing dysphagia across various neurological conditions, but its use in HD remains largely unexplored. Objectives To evaluate swallowing difficulties in HD using the SDQ
Japleen Kaur +3 more
wiley +1 more source
The University of Florida Health Precision Medicine Program plays a crucial role in delivering pharmacogenomics (PGx) result notes to providers who request PGx testing.
Nina Desai +10 more
doaj +1 more source
Abstract Background Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a mutation in the huntingtin gene on chromosome 4, leading to progressive cognitive decline, motor impairment, and functional disability. Although balance impairment is recognized in HD, its onset and evolution with disease stage remain poorly ...
Japleen Kaur +6 more
wiley +1 more source
Abstract Background Plasma biomarkers of neurodegeneration, astrogliosis, and neuroinflammation have been studied as potential biomarkers in neurodegenerative diseases. This study investigated whether these markers may predict phenoconversion to Parkinson's disease or dementia with Lewy bodies (DLB) in idiopathic/isolated REM sleep behavior disorder ...
Aline Delva +9 more
wiley +1 more source

